The U.S. Food and Drug Administration has approved a new device for detecting hypertension, integrating advanced sensor technology. This innovation aims to improve early diagnosis and management of the condition.

Recent developments in diabetes care include smarter insulin delivery systems and an AI-paired artificial pancreas, highlighted on September 11, 2025.

An AI-powered stethoscope was introduced, capable of diagnosing three conditions in 15 seconds. This innovation enhances point-of-care diagnostics in clinical settings. It was featured among key medical breakthroughs of the week.

The FDA granted several breakthrough device designations in September 2025 for innovative medical technologies. These designations expedite the development and review of devices addressing unmet needs. Updates include new approvals and predetermined change control plans.